Newsroom
Keep up with the latest news about Biomoda by subscribing to our newsletter (the sign up form is on the bottom right of this page). For media contact information please visit our contact page.
Latest Press Releases
- European Patent Office Grants Biomoda Patent — 01.24.2012 / 8:00 am
The European Patent Office (EPO) has granted Biomoda, Inc.’s patent application for using our proprietary CyPath® technology to detect cancer and pre-cancerous cells in body fluid and tissue samples. Titled “Composition and Methods for Detecting Pre-Cancerous Conditions In Cell And Tissue Samples Using 5, 10, 15, 20-Tetrakis (Carboxyphenol) Porphine,” EPO patent 1364044 is similar to…
- Biomoda Files New Patent Application To Optimize CyPath® Assay — 11.02.2011 / 8:58 pm
Albuquerque, NM – Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath® diagnostic assay for lung cancer. “This patent is based on a proprietary solid-state, diode-based light source for fluorescent microscopy…
- Shareholder Meeting — 09.05.2011 / 8:35 pm
Biomoda Shareholder Presentation Meeting Results of Shareholder Meeting Proposal 1 The Company’s stockholders elected four individuals to the Board of Directors. Name VotesFor Votes Withheld John J. Cousins 162,513,010 656,872 Maria Zannes 162,800,016 369,866 Lewis White 162,619,007 550,875 David Lambros 162,619,007 550,875 Proposal 2 The Company’s stockholders…
See all news »
President's Column
- January 2012 President’s Column — 01.13.2012 / 5:38 pm
In the January 2012 President’s Column, Biomoda President John Cousins dicusses the Company’s outlook for the New Year and a potential new target for the CyPath® technology. We welcome questions from investors. Please submit questions to investor@biomoda.com. What are you doing to secure new funding for Biomoda? Biomoda and the management team have had to…
- November 2011 President’s Column — 11.25.2011 / 10:26 pm
In the November 2011 President’s Column, Biomoda President John Cousins discusses the possibility of new federal funding and the status of ongoing optimization research on the CyPath® assay. We welcome questions from investors. Please submit questions to investor@biomoda.com. Is Biomoda pursuing additional federal grants or funding? A year ago, Biomoda received nearly a quarter of…
- October 2011 President’s Column — 10.17.2011 / 7:11 pm
In the October 2011 President’s Column, Biomoda President John Cousins discusses Biomoda’s research program to optimize the CyPath® assay and launch the pivotal study. We welcome questions from investors. Please submit questions to investor@biomoda.com. Can you update shareholders on Biomoda’s recent progress? Biomoda continues to work to secure capital to complete our research and commercialize…
See all »
Upcoming Events
- Shareholder Meeting
Biomoda Shareholder Presentation Meeting Results of Shareholder Meeting Proposal 1 The Company’s stockholders elected four individuals to the Board of Directors. Name VotesFor Votes Withheld John J. Cousins 162,513,010 656,872 Maria Zannes 162,800,016 369,866 Lewis White 162,619,007 550,875 David Lambros 162,619,007 550,875 Proposal 2 The Company’s stockholders…
- Rodman & Renshaw Annual Global Investment Conference
September 11-13, 2011 Waldorf Astoria Hotel, NYC, NY Click here to see a list of all Rodman & Renshaw Conferences
- Annual Shareholders Meeting
The Biomoda Annual Shareholders Meeting will be held Wednesday, June 15, 2011, 10 am, at Biomoda Headquarters, 609 Broadway NE, Albuquerque, NM. More information will be posted as it becomes available.
See all events »
